The Contributions of Hypoxia to Poor Outcomes in Pancreatic Cancer

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Dec 16

PMID 36523300

Authors

Maarten F Bijlsma

Affiliations

Soon will be listed here.

Citing Articles

The gene is a potential prognostic biomarker in pancreatic cancer: a bioinformatics analysis.

Ye Q, Chen D, Liu X, Yang B, Li G, Ma J J Gastrointest Oncol. 2024; 15(3):1165-1178.

PMID: 38989440 PMC: 11231855. DOI: 10.21037/jgo-24-227.

References

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

Yamasaki A, Yanai K, Onishi H . Hypoxia and pancreatic ductal adenocarcinoma. Cancer Lett. 2020; 484:9-15. DOI: 10.1016/j.canlet.2020.04.018. View

Pugh C, Ratcliffe P . The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol. 2003; 13(1):83-9. DOI: 10.1016/s1044-579x(02)00103-7. View

Ward P, Thompson C . Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012; 21(3):297-308. PMC: 3311998. DOI: 10.1016/j.ccr.2012.02.014. View

Semenza G . HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell. 2001; 107(1):1-3. DOI: 10.1016/s0092-8674(01)00518-9. View

Mizrahi J, Surana R, Valle J, Shroff R . Pancreatic cancer. Lancet. 2020; 395(10242):2008-2020. DOI: 10.1016/S0140-6736(20)30974-0. View

Bijlsma M, Groot A, Oduro J, Franken R, Schoenmakers S, Peppelenbosch M . Hypoxia induces a hedgehog response mediated by HIF-1alpha. J Cell Mol Med. 2008; 13(8B):2053-2060. PMC: 6512362. DOI: 10.1111/j.1582-4934.2008.00491.x. View

Spivak-Kroizman T, Hostetter G, Posner R, Aziz M, Hu C, Demeure M . Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res. 2013; 73(11):3235-47. PMC: 3782107. DOI: 10.1158/0008-5472.CAN-11-1433. View

Zoa A, Yang Y, Huang W, Yang J, Wang J, Wang H . High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol. Transl Cancer Res. 2022; 11(9):3080-3091. PMC: 9552053. DOI: 10.21037/tcr-22-787. View

10.

Ramjiawan R, Griffioen A, Duda D . Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?. Angiogenesis. 2017; 20(2):185-204. PMC: 5439974. DOI: 10.1007/s10456-017-9552-y. View

11.

Liu D, Steins A, Klaassen R, van der Zalm A, Bennink R, van Tienhoven G . Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma. Biomedicines. 2020; 8(11). PMC: 7690284. DOI: 10.3390/biomedicines8110444. View

12.

Hosein A, Brekken R, Maitra A . Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020; 17(8):487-505. PMC: 8284850. DOI: 10.1038/s41575-020-0300-1. View

13.

Warburg O, GEISSLER A, Lorenz S . [On growth of cancer cells in media in which glucose is replaced by galactose]. Hoppe Seylers Z Physiol Chem. 1967; 348(12):1686-7. View